Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Information Management

By Drug Discovery Trends Editor | October 11, 2007

Velos eResearch Version Velos released Velos eResearch Version 7, bringing a host of advanced features and functions to its customers. In addition to a wide range of functional enhancements, Version 7 further delivers on the power of Web 2.0 technology and system design. The company applies rigorous software quality assurance (SQA) standards in its software development process and is the only software vendor in widespread use at investigator sites that is also CFR Part 11 compliant. Among other advantages, the rigorous SQA process enables customers to rapidly move new releases from test to production environments. With Version 7, some customers moved from test environment to production use in as little as one week. More than 60 functional and system enhancements were incorporated in the release.

With Velos, systems actually used at the site can generate high quality research data, eliminate duplicate data entry, and introduce new levels of efficiency and productivity for investigators and sponsors. To accomplish this, a key is for the system to be organized around individual user workflow and to keep the amount of end user work and training required low relative to system benefits.
www.velos.com

Published in Drug Discovery & Development magazine: Vol. 10, No. 10, October, 2007, p. 42.


Filed Under: Drug Discovery

 

Related Articles Read More >

EVEREST lead investigator on why Dupixent sets a new bar for treating coexisting CRSwNP and asthma
Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE